CJ Bioscience Paid-in Capital Increase Decision
AI summary · Not investment advice
Subsidiary EzBiome will issue 185,667 new shares at KRW 40,671 each to raise KRW 7.3 billion for debt repayment and KRW 0.3 billion for operations.
New shares · common
185,667 shares
Key facts
- Issue price per share
- KRW 40,671
- Offering method
- Rights offering to existing shareholders
- Working capital
- KRW 299.6 million
- Debt repayment
- KRW 7.3 billion
Commentary
AI commentary · Not investment advice
What happened
CJ Bioscience's subsidiary EzBiome decided to issue 185,667 new common shares to raise money. It is a rights offering to existing shareholders (new shares are offered to current holders first). The issue price is KRW 40,671 per share.
In the company's terms
The money has two uses. KRW 7.25 billion goes to repaying debt, and KRW 299.6 million goes to operating funds.
What changes for shareholders
Before the offering, EzBiome had 99,444 common shares. Each existing share entitles the holder to 1.867050 new shares. The right to subscribe to new shares cannot be transferred to others. Payment for the new shares is scheduled for Nov 23, 2026.
Comments
No comments yet
Comments from shareholders will appear here.
Ad
Verify your holdings and catch the next disclosure
Verify the stocks you hold and get new disclosures as app alerts.

App design sample
Get the next disclosure as an app alert
Get app alerts for new disclosures and stake changes on your watchlist
C